Raise awareness this Rheumatological Diseases Awareness Month. Know the symptoms, share knowledge, and support those affected. #RheumAwareness #FightRheumatology #RheumatologicalDiseases #KnowTheSigns #AsterBangalore #AsterHospitals
Aster Hospitals, Bangalore’s Post
More Relevant Posts
-
🫁 Today is World Asthma Day. Did you know that #asthma and #tuberculosis (TB) share symptoms, such as coughing and shortness of breath? 😮💨 Because of this, TB might be misdiagnosed with asthma. However, it is crucial to distinguish between these diseases because both the cause and the treatment are very different! We are working tirelessly to help people worldwide to get the right diagnosis and treatment timely💪. Only then can we end #TB and other similar diseases. #WorldAsthmaDay #EndTB #YesWeCanEndTB #TogetherWeCanEndTB
To view or add a comment, sign in
-
May marks Lyme Disease Awareness Month, a crucial time for educating the public about this increasingly common disease. Lyme disease was first identified in the 1970s in Lyme, Connecticut, by researchers investigating why unusually large numbers of children were being diagnosed with juvenile arthritis. This investigation led to the discovery of Lyme disease by Willy Burgdorfer, and the bacterium responsible, Borrelia burgdorferi. Transmitted through the bite of infected black-legged ticks, early detection is key to effective treatment. The most recognizable sign of Lyme disease is the Erythema Migrans rash, often resembling a bullseye, which appears in sometimes less than 40% of infected persons. Accompanying symptoms include fever, chills, headache, fatigue, and muscle and joint aches. Recognizing these signs early can drastically improve treatment outcomes, and I encourage anyone who suspects they might be infected to consult their healthcare provider promptly. Sharing personal stories can immensely help in raising awareness, and Dr. Victoria Lau is one to ask about her story! If you think you may be infected, or you have been in your past, please do seek care at All Seasons Integrative Health! #AllSeasonsHealing #IntegrativeHealthSolutions #NaturalWellnessJourney #WholeBodyBalance #ChiropracticCareForAll #HealNaturallyWithAllSeasons #EmpowerYourHealth #LiveYourFullPotential #BeyondPainRelief #HolisticHealingApproach #MultifacetedApproach #AllSeasonsIntegrativeHealth #LymeDisease #LymeAwareness #DrPaulBekkum #DrVictoriaLau #DrCarlyDropik
To view or add a comment, sign in
-
May marks Lyme Disease Awareness Month, a crucial time for educating the public about this increasingly common disease. Lyme disease was first identified in the 1970s in Lyme, Connecticut, by researchers investigating why unusually large numbers of children were being diagnosed with juvenile arthritis. This investigation led to the discovery of Lyme disease by Willy Burgdorfer, and the bacterium responsible, Borrelia burgdorferi. Transmitted through the bite of infected black-legged ticks, early detection is key to effective treatment. The most recognizable sign of Lyme disease is the Erythema Migrans rash, often resembling a bullseye, which appears in sometimes less than 40% of infected persons. Accompanying symptoms include fever, chills, headache, fatigue, and muscle and joint aches. Recognizing these signs early can drastically improve treatment outcomes, and I encourage anyone who suspects they might be infected to consult their healthcare provider promptly. Sharing personal stories can immensely help in raising awareness, and Dr. Victoria Lau is one to ask about her story! If you think you may be infected, or you have been in your past, please do seek care at All Seasons Integrative Health! #AllSeasonsHealing #IntegrativeHealthSolutions #NaturalWellnessJourney #WholeBodyBalance #ChiropracticCareForAll #HealNaturallyWithAllSeasons #EmpowerYourHealth #LiveYourFullPotential #BeyondPainRelief #HolisticHealingApproach #MultifacetedApproach #AllSeasonsIntegrativeHealth #LymeDisease #LymeAwareness #DrPaulBekkum #DrVictoriaLau #DrCarlyDropik
To view or add a comment, sign in
-
CBABE: The easiest way to remember the obstructive lung diseases. ✔️ C - Cystic Fibrosis B - Bronchiectasis A - Asthma B - Bronchitis (Chronic) E - Emphysema #respiratorytherapy #respiratorytherapist #respiratorytherapystudent #respiratorystudent #copd #asthma #cbabe #cysticfibrosis
To view or add a comment, sign in
-
On the occasion of World Vitiligo Day, let's shed light on vitiligo and spread awareness! Vitiligo, also known as the white spot disease, affects about 1% of the world's population. It's a condition where pigment cells in the skin are lost, leading to distinct white patches. Regular health check-ups are recommended for individuals with vitiligo to monitor and manage any associated autoimmune conditions such as diabetes and thyroid disorders. #CitizensSpecialtyHospital #multispecialityhospital #WorldVitiligoDay #Vitiligo
To view or add a comment, sign in
-
It's here! The KDIGO 2024 CKD Guideline Executive Summary was released today in the April Issue of Kidney International (KI). Read the Executive Summary in KI: https://lnkd.in/grYUb6mu Download the PDF: https://lnkd.in/g9-UEiMX The KDIGO 2024 CKD Guideline, based on the best current evidence, indicates exciting new approaches to management strategies and treatment options for people living with #CKD. The goal is to improve symptom management, disease modification, and person-centered approaches while also recognizing the heterogeneity of CKD. The fact that new therapies exist and others are being evaluated heralds an exciting time for people living with #kidney diseases.
To view or add a comment, sign in
-
The KDIGO 2024 CKD Guidelines are here! This is a major update to the 2012 guidelines which have guided CKD management for many years. Great job KDIGO on synthesizing the latest evidence to guide nephrologists in CKD care!
It's here! The KDIGO 2024 CKD Guideline Executive Summary was released today in the April Issue of Kidney International (KI). Read the Executive Summary in KI: https://lnkd.in/grYUb6mu Download the PDF: https://lnkd.in/g9-UEiMX The KDIGO 2024 CKD Guideline, based on the best current evidence, indicates exciting new approaches to management strategies and treatment options for people living with #CKD. The goal is to improve symptom management, disease modification, and person-centered approaches while also recognizing the heterogeneity of CKD. The fact that new therapies exist and others are being evaluated heralds an exciting time for people living with #kidney diseases.
To view or add a comment, sign in
-
It’s increasingly clear now that a regular update and in some cases a rewrite of guidelines need to be done. Newer tools, tech and specialities are available to help #healthcare innovate & improve how to treat #patients. Here’s one for clinicians.
It's here! The KDIGO 2024 CKD Guideline Executive Summary was released today in the April Issue of Kidney International (KI). Read the Executive Summary in KI: https://lnkd.in/grYUb6mu Download the PDF: https://lnkd.in/g9-UEiMX The KDIGO 2024 CKD Guideline, based on the best current evidence, indicates exciting new approaches to management strategies and treatment options for people living with #CKD. The goal is to improve symptom management, disease modification, and person-centered approaches while also recognizing the heterogeneity of CKD. The fact that new therapies exist and others are being evaluated heralds an exciting time for people living with #kidney diseases.
To view or add a comment, sign in
-
🌟 Exciting News in Kidney Disease Management! 🌟 📚 Just Released: A Comprehensive Guidance Document on Chronic Kidney Disease (CKD) Management 🔍 Multinational population studies based on CKD-PC 2023 analyses highlight the incremental increase in the association of all CKD complications with worse categories of estimated glomerular filtration rate (eGFR) and albuminuria. 💡 Key Highlights: -Emphasis on the importance of detecting CKD early, especially in high-risk populations. -Recommendations for accurate assessment of GFR and urine albumin-to-creatinine ratio (ACR). -Importance of using validated risk equations to estimate absolute risk of kidney failure. -Comprehensive discussion on delaying CKD progression and managing complications. -Insights into cardiovascular risk factor modification and drug stewardship in CKD. -Optimal models of care, including the value of multidisciplinary teams and advanced care planning. 🔬 Newer data on treating hyperuricemia were evaluated, with no support for targeting hyperuricemia in the absence of symptoms. 📊 Tables provided for "expected" values for common laboratory tests by eGFR to aid in identifying aberrant values. 🚀 Conclusion: This guidance document offers exciting new approaches to CKD management, aiming to improve symptom management, disease modification, and person-centered care. #KidneyDisease #CKDManagement #Healthcare #MedicalResearch #PatientCare #HealthTech #Nephrology #ChronicDiseaseManagement
It's here! The KDIGO 2024 CKD Guideline Executive Summary was released today in the April Issue of Kidney International (KI). Read the Executive Summary in KI: https://lnkd.in/grYUb6mu Download the PDF: https://lnkd.in/g9-UEiMX The KDIGO 2024 CKD Guideline, based on the best current evidence, indicates exciting new approaches to management strategies and treatment options for people living with #CKD. The goal is to improve symptom management, disease modification, and person-centered approaches while also recognizing the heterogeneity of CKD. The fact that new therapies exist and others are being evaluated heralds an exciting time for people living with #kidney diseases.
To view or add a comment, sign in
-
The KDIGO 2024 CKD Guidebline Executive Summary.
It's here! The KDIGO 2024 CKD Guideline Executive Summary was released today in the April Issue of Kidney International (KI). Read the Executive Summary in KI: https://lnkd.in/grYUb6mu Download the PDF: https://lnkd.in/g9-UEiMX The KDIGO 2024 CKD Guideline, based on the best current evidence, indicates exciting new approaches to management strategies and treatment options for people living with #CKD. The goal is to improve symptom management, disease modification, and person-centered approaches while also recognizing the heterogeneity of CKD. The fact that new therapies exist and others are being evaluated heralds an exciting time for people living with #kidney diseases.
To view or add a comment, sign in
54,617 followers